Moreover, the GCKR variant increased the susceptibility to fibrosis onset coupled with increased circulating TG in adult NAFLD patients, without affecting LDL and HDL cholesterol levels and the risk of coronary artery disease (CAD) [142,148]. This evidence concerns the gene GCKR and coronary artery disorder.